Bilobalide regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway

• Published in: Neurochemistry international 2011-08, Vol.59 (1), p.59-64
• Main Authors: Shi, Chun, Wu, Fengming, Xu, Jie, Zou, Juntao
• Format: Article
• Language: English
• Subjects: 1-Phosphatidylinositol 3-kinase; Amyloid beta-Protein Precursor - metabolism; Bilobalide (BB); Biological and medical sciences; Cell Line, Tumor; Cyclopentanes - pharmacology; Disintegrin and metalloproteinase domain-containing protein 10 (ADAM10); Fundamental and applied biological sciences. Psychology; Furans - pharmacology; Ginkgo biloba; Ginkgolides - pharmacology; Humans; Phosphatidyl inositol 3-kinase (PI3K); Phosphatidylinositol 3-Kinases - metabolism; Protein Kinase C - metabolism; Soluble amyloid precursor protein (sAPPα); Vertebrates: nervous system and sense organs
• ISSN: 0197-0186; 1872-9754
• DOI: 10.1016/j.neuint.2011.03.028

► Bilobalide promotes α-secretase cleavage of APP. ► The PI3K pathway mediates BB regulation of APP processing. ► BB modulates intracellular APP trafficking in a very short time via the PI3K pathway. ► BB up-regulates ADAM10 in a longer time via the PI3K pathway. Bilobalide (BB) is a sesquiterpenoid extracted from Ginkgo biloba leaves. An increasing number of studies have demonstrated its neuroprotective effects. The neuroprotective mechanisms may be associated with modulation of intracellular signaling cascades such as the phosphatidyl inositol 3-kinase (PI3K) pathway. Using differentiated SH-SY5Y cells, this study investigated whether BB modulation of intracellular signaling pathways, such as the protein kinase C (PKC) and PI3K pathways, contributes to amyloid precursor protein (APP) metabolism, a key event in the pathogenesis of Alzheimer’s disease (AD). We demonstrated in this study that BB enhanced the secretion of α-secretase-cleaved soluble amyloid precursor protein (sAPPα, a by-product of non-amyloidogenic processing of APP) and decreased the β amyloid protein (Aβ, a by-product of amyloidogenic processing of APP) via PI3K-dependent pathway. The PI3K pathway mediated the rapid effect of BB on APP processing possibly via regulation of intracellular APP trafficking. After longer time BB incubation (12 h), this effect was reinforced by PI3K pathway-mediated up-regulation of disintegrin and metalloproteinase domain-containing protein 10 (ADAM10, an α-secretase candidate). Given the strong association between APP metabolism and AD pathogenesis, the ability of BB to regulate APP processing suggests its potential use in AD prevention.